Hover to zoom

GLP-1 & MetabolicModified peptide fragment (hGH 176–191 analog)

AOD-9604

$79.99

5 mg· 2 strengths available

AOD-9604 is a synthetic 16-amino-acid peptide derived from the C-terminal region (residues 176–191) of human growth hormone, with an added N-terminal tyrosine.

It is studied because it isolates a defined fragment of the growth-hormone sequence, allowing investigators to examine fragment-associated activity in adipocyte and lipid-metabolism models separately from the broader signaling profile of the intact hormone.

Research areas

Adipocyte metabolismLipid metabolism researchPeptide fragment studiesPreclinical research

Form: Lyophilized (freeze-dried)

Compound class: Modified peptide fragment (hGH 176–191 analog)
Research category: GLP-1 & Metabolic
SKU: NVR-AOD-9604-5MG
Alternate name: AOD
Appearance: White lyophilized powder
Storage: Store lyophilized at −20 °C. Protect from light and moisture.

Research use only

Select strength

Cost per mg shown for each option

$79.99per 5 mg$16.00/mg

For research use only — not for human or animal consumption.

Supplied solely for legitimate laboratory and research purposes. Not for medical or veterinary use, diagnosis, treatment, or prevention of disease.

Research Grade

Batch Documentation

Research Use Only

U.S.-Based Fulfillment

What you should know

More detail on AOD-9604.

Analytical values reflect per-lot documentation and appear once a batch is released.

Compound

Fragment-based research is a common strategy for mapping which portion of a large hormone is responsible for a given cellular response. AOD-9604 emerged from that approach applied to human growth hormone. Laboratory studies have characterized its behavior in adipose-tissue and cultured-cell models, typically measuring markers of lipid turnover rather than receptor binding, since the fragment does not engage the growth hormone receptor in the same manner as the full-length hormone. Its mechanism remains incompletely defined and is an ongoing subject of preclinical investigation.

Peptide class

Modified peptide fragment (hGH 176–191 analog)

Mechanism (research context)

In research literature, AOD-9604 has been characterized in cell and animal models of lipolysis. It is studied for its effect on adipocyte metabolism without engaging the growth hormone receptor in the same manner as full-length hGH.

Why it is studied

AOD-9604 provides a defined fragment tool that separates lipolytic-adjacent activity from the broader signaling profile of intact growth hormone, which is useful for investigators dissecting fat-metabolism pathways.

Current areas of research

Adipocyte metabolismLipid metabolism researchPeptide fragment studiesPreclinical research

Topics reflect published preclinical and in vitro research. Reference only — not a claim of clinical outcomes.

Scientific background

The 176–191 fragment of hGH was investigated in the 1990s after work at Monash University suggested that lipolytic activity of growth hormone could be localized to the C-terminal region.

AOD-9604 was subsequently developed as a synthetic analog of that fragment and has been the subject of published preclinical work exploring its metabolic effects.

Contemporary laboratory research continues to use AOD-9604 as a defined-sequence reference peptide in adipocyte and metabolic in vitro systems.

Batch number

Batch documentation will be added when inventory is released.

Purity

Batch documentation will be added when inventory is released.

Analytical method

RP-HPLC & mass spectrometry (per lot documentation)

Testing laboratory

Independent third-party analytical laboratory

Batch documentation will be added when inventory is released. Once a batch is released, its analytical records and Certificate of Analysis are linked here. Requests: grant@novarynresearch.com.

Research Grade

Batch Documentation Where Available

Laboratory Handling Guidance

Laboratory Use Only

Laboratory concentration calculator

Use the selected research-material amount and your chosen total liquid volume to calculate laboratory concentration.

Material amount

5 mgSelected

From the selected AOD-9604 strength.

Total liquid volume

Mathematical laboratory concentration calculation only. This tool does not provide preparation recommendations of any kind.

Calculations are a laboratory reference for in vitro work only. No preparation, administration, or human-use guidance is provided.

Storage

Store lyophilized at −20 °C. Protect from light and moisture.

Form

Lyophilized (freeze-dried) powder

Shipping conditions

Ships from the United States in packaging appropriate to the product's storage requirements. Cold-chain packaging is used where required.

Handling recommendations

Handle per institutional laboratory protocols. Wear appropriate PPE, minimize exposure to light and moisture, and record lot information on the working aliquot.

Product name

AOD-9604

Peptide class

Modified peptide fragment (hGH 176–191 analog)

Research category

GLP-1 & Metabolic

Available sizes

5 mg — $79.99 10 mg — $129.99

Appearance

White lyophilized powder

Delivery form

Lyophilized (freeze-dried) powder

CAS number

Batch documentation will be added when inventory is released.

Molecular formula

Batch documentation will be added when inventory is released.

Molecular weight

Batch documentation will be added when inventory is released.

Purity specification

≥ 98% (per lot documentation, when available)

Solubility

Batch documentation will be added when inventory is released.

Storage temperature

Store lyophilized at −20 °C. Protect from light and moisture.

Shelf life

24 months lyophilized under recommended storage

Laboratory use

For in vitro research use only. Not for human or veterinary use.

Alternate names

AOD · AOD9604 · hGH fragment 176-191

Subscribe & Save

Every 30 days · 10% off · Every 60 days · 15% off · Every 90 days · 20% off

It is an analog of the human growth hormone 176–191 fragment with an additional N-terminal tyrosine.

Lyophilized material is prepared with an appropriate laboratory solvent according to the investigator's own protocol.

Lyophilized materials are typically reconstituted with bacteriostatic water. Follow institutional protocols and consult the applicable batch documentation when available.

Materials ship in insulated packaging appropriate to their handling requirements. Cold-chain packaging is used where required by the product's storage guidance.

Batch-specific documentation, including a Certificate of Analysis, is provided when available for the released lot. Contact grant@novarynresearch.com for outstanding requests.